Skip to main content

Newly published clinical study article demonstrates “Survival From Revision Surgery for New Rigicon Infla10® Three-piece Inflatable Penile Prosthesis Is Comparable to Preceding Devices”


A recent clinical study article published titled “Survival From Revision Surgery for New Rigicon Infla10 Three-piece Inflatable Penile Prosthesis Is Comparable to Preceding Devices.” This study highlights the safety and performance of the Rigicon Infla10 Inflatable Penile Prosthesis, showcasing its potential as an effective solution in prosthetic urology.

In its initial 2 to 3 years of availability, the Rigicon Infla10 Inflatable Penile Prosthesis has shown notable resilience against the need for revision, similar to well-established already in-market devices. Analyzing data from the first 535 patients who received the Rigicon Infla10 (between January 2019 and August 2022), the study emphasizes its safety record, mechanical stability, infection incidence, and patient satisfaction in comparison with other devices.

Key findings echo the preliminary research, underlining the Infla10’s impressive durability. Mechanical Stability: The Rigicon Infla10’s mechanical failure rate is comparable to other available devices, signifying its long-term effectiveness.

Another key finding showed that Rigicon Infla10’s infection rate is found to be very low, with only a single instance among the 535 patients under observation. The infection rate of the Infla10 three-piece IPP with 103 different implanting surgeons is well within expectations.

Renowned urologist Dr. Steven K. Wilson, a contributor to the study, notes, “The Rigicon Infla10 marks progress in prosthetic urology. The data reaffirms the company’s commitment to innovative prosthetic urology solutions, providing reliable options that make a positive impact on patients’ lives.”

About Erectile Dysfunction

Erectile Dysfunction, or ED, is the inability to achieve or sustain an erection suitable for sexual intercourse. ED is a common male sexual disorder and may maintain a permanent course as some men cannot have any erection for the remaining part of their life. ED might have a deep impact on the quality of life and social relationships of the patient.

ED may be basically caused by various diseases and disorders including heart disease, diabetes, pelvic area damage due to surgery, accidents or radiation therapy, benign prostatic hyperplasia (BPH, which is non-cancerous enlargement of the prostate tissue), disorders associated with low testosterone levels, Parkinson’s disease, and other neurologic diseases.

About Inflatable Penile Prosthesis

About Inflatable Penile Prosthesis (Three–Piece Inflatable Penile Prosthesis)

Inflatable devices, the most common type of penile implant used, can be inflated to create an erection, and deflated at other times. Three-piece inflatable implants use a fluid-filled reservoir implanted under the abdominal wall, a pump and a release valve placed inside the scrotum, and two inflatable cylinders inside the penis. (Source: Mayo Clinic)

Penile implant surgery is considered a gold standard therapy for men with erectile dysfunction.

About Rigicon

Rigicon specializes in the research, development, and manufacturing of innovative prosthetic urology solutions with 30 years’ of experience in Urology. We focus on creating a comprehensive product portfolio for urologist(s) around the world. Committed to improving the quality of life for patients, Rigicon focuses on providing cutting-edge treatments that address various urological conditions, including erectile dysfunction and urinary incontinence.


Release Date: September 2, 2023


EVENTS
BAUS NWU 2024

North West Regional Meeting

January 25-26, 2024

Manchester, UK

ESSM 2024

European Society for Sexual Medicine (ESSM) Congress

February 8-10, 2024 | Bari, Italy

USANZ 2024

The Urological Society of Australia and New Zealand (USANZ) 76th Annual Scientific Meeting including the ANZUNS 28thAnnual Meeting

February 24-27, 2024 | Adelaide, Australia

EAU 2024

EAU24: The 39th Annual Congress

April 5-8, 2024 | Paris, France

AUA 2024

American Urological Association Annual Meeting 2024

May 3-6, 2024 | San Antonio, USA

 


Copyright © 2023 Rigicon, Inc. | All rights reserved. | REV21062023